Decoding Semaglutide Semaglutide, a promising medication in the medical weight loss landscape, belongs to a class of drugs known as GLP-1 receptor agonists
Marys Hospital, College of Medicine, The Catholic University of Korea, 222 Banpodaero, Seocho-gu, Seoul 06591, Korea E-mail: [email protected] Copyright 2024 Korean Diabetes Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited
As a potential physiological regulator, it stimulates glucose transport and glycogen synthesis in osteoblasts even at significantly lower concentrations than insulin
It sits in a comparison page where the details that matter most are access, cost, clinical fit, and what a licensed clinician should confirm and should help with provider evaluation and access
10.3389/fnagi.2021.659402 Front